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Low abundance of the matrix arm of complex I
in mitochondria predicts longevity in mice
Satomi Miwa1, Howsun Jow2, Karen Baty3, Amy Johnson1, Rafal Czapiewski1, Gabriele Saretzki1,
Achim Treumann3 & Thomas von Zglinicki1
Mitochondrial function is an important determinant of the ageing process; however, the
mitochondrial properties that enable longevity are not well understood. Here we show that
optimal assembly of mitochondrial complex I predicts longevity in mice. Using an unbiased
high-coverage high-confidence approach, we demonstrate that electron transport chain
proteins, especially the matrix arm subunits of complex I, are decreased in young long-living
mice, which is associated with improved complex I assembly, higher complex I-linked state 3
oxygen consumption rates and decreased superoxide production, whereas the opposite is
seen in old mice. Disruption of complex I assembly reduces oxidative metabolism with
concomitant increase in mitochondrial superoxide production. This is rescued by knockdown
of the mitochondrial chaperone, prohibitin. Disrupted complex I assembly causes premature
senescence in primary cells. We propose that lower abundance of free catalytic complex I
components supports complex I assembly, efficacy of substrate utilization and minimal ROS
production, enabling enhanced longevity.
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M
itochondria perform vital functions in life such as they
provide energy (ATP), generate iron–sulphur clusters,
participate in Ca2þ regulation and have major roles in
fatty acid and amino-acid metabolism. They also produce reactive
oxygen species (ROS) as metabolic by-products that can damage
cellular components and participate in cellular signalling
pathways. Mitochondria have long been regarded as crucial in
the ageing process. This was originally associated with the
(mitochondrial) oxidative stress theory of ageing1. However, a
recent research has revealed a more complex picture by
uncoupling lifespan extension from a decrease in mitochondrial
ROS generation or oxidative damage in multiple species2,3, and
other relevant aspects associated with mitochondrial function
such as stress responses, apoptosis and cell senescence have also
been attracting attention.
Mitochondrial biogenesis is an extremely complex process
integrating the intra-mitochondrial synthesis of 13 electron
transport chain (ETC) proteins coded by the mitochondrial
DNA with far more than 1,000 additional proteins that are
synthesized in the cytosol as pre-proteins and imported into
mitochondria through specific transporters. There are several
assembly factors for the ETC, and mitochondrial protein
chaperones such as prohibitin (PhB) are thought to be involved
in a dynamic balance in the composition of the mitochondriome
that determines mitochondrial function4. The dynamics of the
mitochondriome5 is further determined by targeted turnover6.
We aimed to identify in an unbiased approach the proteome
composition of mitochondria that might predict longevity in
mammals. We reasoned that such a ‘longevity-enabling pheno-
type’ of mitochondria should be (i) evident in mitochondria from
long-living animals at young age (that is, before the death of the
first member of the cohort); (ii) common in disparate longevity
models and tissues; and (iii) counteracted by ageing. Reduced
abundance of ETC proteins and of matrix arm subunits of
complex I in particular was found in young mice from long-living
mouse cohorts, which was associated with improved complex I
assembly, higher state 3 oxygen consumption rates and decreased
complex I-linked superoxide production, and was reversed in old
mice. Moreover, suppression of complex I assembly decreased
mitochondrial oxidative metabolism, increased mitochondrial
ROS production and precipitated premature senescence. We
suggest that partially assembled matrix arm subcomplexes of
complex I, which contain the catalytic subunits, might be
detrimental as they only contribute to ROS formation without
facilitating electron transport activity and proton pumping.
Minimizing the abundance of free catalytic complex I compo-
nents might be an essential feature of a longevity-enabling
mitochondrial phenotype in mammals.
Results
Low abundance of ETC complexes associates with longevity. To
perform an unbiased analysis of mitochondrial protein compo-
sition as potential predictor of longevity, we analysed the mouse
liver proteome at young age (100% cohort members alive) in two
long-lived mice models: the ICRFa strain, a C57Bl/6 substrain7
with significantly extended longevity under standard ad libitum
(AL)-fed condition (P¼ 0.017; Fig. 1a); and C57Bl/6 subjected to
dietary restriction (DR, 60% of AL food intake) from 3 months of
age onwards. DR significantly extended lifespan beyond both
AL C57Bl/6 (log-rank test, P¼ 0.0073) and AL ICRFa mice
(P¼ 0.0085; Fig. 1a). We addressed ageing-related changes by
comparing young (7–8 months) and old (30–32 months) ICRFa
mice. DR mice were significantly lighter than the AL C57Bl/6, AL
ICRFa and old ICRFa mice, whereas there were no differences in
body weights among the non-DR mice groups (analysis of
variance, P¼ 0.05; Supplementary Fig. 1). Food intake was not
different between AL ICFRa and AL C7Bl/6 mice, suggesting that
the extended lifespan in ICRFa mice is not caused by a concealed
DR effect.
We studied liver mitochondrial function in C57Bl/6 during
ageing in both AL- and DR-fed mice. Oxygen consumption rates
under phosphorylating condition (state 3) using either a complex
I-linked substrate (pyruvate plus malate) or a complex II-linked
substrate (succinate; Fig. 1b) progressively declined with age in
AL mice but were maintained under DR up to an age of
37 months, that is, beyond the maximum lifespan of the AL mice.
Hydrogen peroxide release from complex I was higher under AL
than under DR up to an age of 30 months. However, DR only
postponed the age-dependent increase and did not prevent it: DR
mice at 37 months of age (that is, at equivalent survival rate to
30-month-old AL mice) showed hydrogen peroxide release from
complex I as high as AL mice at 30 months (Fig. 1c). There were
only minor differences in hydrogen peroxide release from sites
other than complex I (Fig. 1c). In a comparison between ICRFa
and C57Bl/6 mice, longer lifespan in ICRFa was also associated
with lower hydrogen peroxide release from complex I in isolated
liver and brain mitochondria (Supplementary Fig. 2).
Proteomic analysis was performed in two separate 6-plex
tandem mass tag (TMT) labelling experiments using one-pooled
sample in each for cross-standardization. After imposing a 1%
false discovery rate (FDR) filter, we identified 7,047 and 6,704
peptides in the two experiments, respectively, and quantified a
total of 631 proteins (531 and 497 proteins per experiment)
(Supplementary Data 1–3). This represents about half of the
mouse mitochondrial proteins in the MitoCarta database and is
similar to published data4. The molecular weight distribution of
the identified proteins mirrored that of all mitochondrial proteins
according to the MitoCarta and MitoMiner8 databases
(Supplementary Fig. 3). Our analysis quantified 57 out of the
96 known mouse ETC proteins, namely 67% of complex I
proteins, 50% of complex II, 63% of complex III, 46% of complex
IV and 76% of complex V. One-hundred seventy-seven proteins
showed confidently different abundances in at least one of the
three comparisons performed (Supplementary Data 1–3). The
number of differentially abundant proteins was the largest (131
proteins) in the AL–DR comparison in C57Bl/6 mice, whereas
there were only 57 and 52 differentially abundant proteins for the
young C57Bl6–ICRFa and the young–old ICRFa comparisons,
respectively (Fig. 1d). In general, proteins that were less abundant
in the longevity models (and more abundant in old mice livers)
tended to be smaller than those that were more frequent in long-
living mice (Fig. 1e).
Out of the 13 proteins that were different in abundance in all
three comparisons (Fig. 1d), 12 were possibly implicated with
longevity because they were less abundant in both longevity
models. Moreover, 11 of them were increased in old mice
(Supplementary Table 1), together suggesting that low abundance
of these proteins at a relatively young age by either genetic or
environmental manipulation might predispose to longevity.
These proteins included both PhB and PhB 2, and the majority
(8 out of 13) were components of the ETC (complexes I, III and
V; Supplementary Table 1).
To identify the functional traits of liver mitochondria
associated with longevity, we performed mitochondria-specific
KEGG pathway enrichment analysis based on the proteins that
were more abundant in liver mitochondria from young C57Bl/6
mice under DR in comparison with AL. A wide range of diverse
metabolic pathways, notably those associated with the Krebs cycle
and fatty acid and amino-acid metabolism, was enriched under
DR (Supplementary Table 2). However, few of these pathways
were similarly enriched in young long-living ICRFa mice or were
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depleted in old mice. Not a single pathway changed consistently
in all three comparisons (Supplementary Table 2), indicating that
most of the metabolic pathways that are more abundant under
DR are not general longevity-assurance mechanisms. In contrast,
there were only nine KEGG pathways significantly enriched in an
analysis based on proteins less abundant in DR (Supplementary
Table 3). Importantly, the four highest ranking of these were also
significantly enriched in an analysis based on less abundant
proteins in young ICRFa mice (Supplementary Table 3) and
equally so in an analysis based on proteins more abundant in old
animals (Supplementary Table 3). These four pathways (oxidative
phosphorylation, Parkinson’s disease, Huntington’s disease and
Alzheimer’s disease) include high proportions of ETC proteins,
suggesting that multiple ETC proteins within liver mitochondria
are reduced at young age in a longevity phenotype but increased
with age.
As we were able to quantify the majority of ETC proteins, we
examined the changes of the individual ETC subunits in all three
comparisons in detail (Fig. 2a–c). The abundance of numerous
subunits of complexes I, III, IV and V (but not of complex II) was
reduced in both long-lived mouse models, which was generally
reversed in old mice (Fig. 2a–c). There was no evidence for an
induction of a mitochondrial unfolded protein response in the
long-lived mice with low ETC abundance: several mitochondrial
heat-shock proteins (HSPD1, HSPA9 and DSPE1) and the Clpp1
protease were not changed in any of comparisons, whereas heat-
shock proteins HSPA5 and HSP90D1 were decreased under DR
(Supplementary Data 1–3).
Low abundance of CI matrix subunits in long-lived mice.
Strikingly there was a highly skewed pattern of protein abundance
changes within complex I. Reduced abundance of complex I
subunits in both long-living mice models occurred almost
exclusively in subunits localized in the matrix arm while
membrane arm subunits were hardly affected (Fig. 2a,b). This
pattern was partially reversed in the aged mice (Fig. 2c). The
abundances of PhB and PhB 2, which function as chaperones for
ETC proteins and/or as structural scaffolds, paralleled the
changes in matrix arm subunits with strong statistical confidence
and large fold differences (Supplementary Table 1).
We confirmed these observations in a series of SDS–PAGE
western blot experiments, by measuring the ratios of selected
matrix subunits (NDUFS3 and NDUFV2) and PhB to the
membrane subunits NDUFB9 and NDUFA9, which is located at
the junction between membrane and matrix arm and is involved
in stabilizing this junction9 (Fig. 3a). In agreement with the
proteomics results, we found a decreased ratio of matrix subunits
and PhB to membrane subunits under DR (Fig. 3b) and in liver
mitochondria from young long-lived ICRFa mice (Fig. 3c), which
was reversed in aged liver mitochondria (Fig. 3d).
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Figure 1 | Longevity and liver mitochondrial function in male long-living mice. (a) Kaplan-Meier survival curves (right censored) of male C57Bl/6
(red) and ICRFa (green) mice under ad libitum (AL) feeding and of C57Bl/6 mice under 40% DR from an age of 3 months onwards (blue). Group sizes
were (censored events in brackets): C57Bl/6 AL 310 (172), C57Bl/6 DR 241 (157) and IRCFa 2391 (1,061). (b) State 3 oxygen consumption rates of purified
liver mitochondria from C57Bl/6 mice under AL and DR, respectively, with pyruvate/malate (top) and succinate (bottom) as substrate. Data are
mean±s.e.m., n¼4 animals per group. (c) H2O2 release from purified liver mitochondria from C57Bl/6 mice under AL and DR, respectively. Data are
mean±s.e.m., n¼4. Top: pyruvate/malate plus rotenone, indicating maximum ROS production from complex I (CI). Bottom: succinate plus rotenone,
indicating ROS production from sites other than complex I. (d) Numbers of confidently changed proteins in all comparisons. (e) Molecular mass
distributions for differentially enriched proteins under DR (blue), in young ICFRa (green) and in old ICRFa (pink).
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The low relative abundance of matrix subunits of complex I in
long-lived mice was not confined to liver. Ratios of matrix
subunits NDUFS3 and NDUFV2 to membrane subunit NDUFA9
(as well as PhB/NDUFA9) were indeed lower in brain
mitochondria from 15-month-old mice that were subjected to
DR from 3 months of age (Fig. 3e,f). Similarly in skeletal muscle
mitochondria, matrix subunit NDUFV2 showed a decreased
abundance in relation to membrane subunit NDUFB9 in DR
compared with controls (Fig. 3g,h).
To see whether the observations made so far are valid in
further longevity models, we examined brain and liver mitochon-
dria from mice fed with rapamycin for 4 months. Rapamycin, an
inhibitor of the TOR (target of rapamycin) nutrient sensing
pathway, is known to extend lifespan in mice10. Liver (Fig. 4a)
and brain (Fig. 4e) mitochondria from rapamycin-fed mice did
not show altered state 3 oxygen consumption rates nor
respiratory control ratio, but hydrogen peroxide release from
complex I from both tissue mitochondria was lower (Fig. 4b,f).
Importantly, ratios of matrix subunits (NDUFS3 and NDUFV2)
as well as PhB to membrane subunits (NDUFA9 and NDUFB9)
were generally lower in rapamycin-fed animals than in controls in
both liver (Fig. 4c,d, see Supplementary Fig. 4 for uncropped
scans) and brain (Fig. 4g,h) mitochondria. Thus, a shift to lower
abundance of complex I matrix subunits is associated with lower
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Figure 2 | ETC proteins are less abundant in long-living mice and increase in old mice. Heatmaps show changes in abundance of all ETC proteins
in the comparisons young DR versus young AL C57Bl/6 (a), young ICRFa versus young C57Bl/6 (b) and old versus young ICRFa (c). CI and CV reach out
from the inner membrane into the matrix space (upward). Grey symbols represent proteins not identified; and black/white symbols represent abundance
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hydrogen peroxide release and a longevity phenotype in multiple
tissues and multiple models of longevity.
Assembly of complex I is more complete in long-lived mice.
Mitochondrial complex I is assembled in multiple stages11. In
HEK293 cells at steady state, complex I subunits exist in a
dynamic equilibrium between subcomplexes, the fully assembled
holocomplex and supercomplexes12,13. We hypothesize that
relatively lower abundance of matrix to membrane arm
components might shift this equilibrium towards less abundant
subcomplexes and more fully assembled holocomplex, thus be
associated with tighter control of complex I assembly. To test
this possibility, we examined the complex I assembly status
in liver mitochondria under DR using blue native (BN) gel
electrophoresis followed by western blotting (Fig. 5a). Complex I
activity was preferentially found at the level of fully assembled
complex I. Multiple weak activity bands were visible both at
supercomplex level and at lower molecular weights (Fig. 5a,c,e);
however, the sensitivity of the in-gel assay was not sufficient to
quantify differences between cohorts. Western blotting of BN gels
revealed differential fractions of the tested subunits in smaller
subcomplexes (Fig. 5a). In DR mitochondria, relative amounts of
all subunits in the partially assembled complexes tended to be
lower than in AL mitochondria, and this was significant for both
matrix arm subunits and for NDUFA9 (Fig. 5b). In contrast,
complex II activity and the relative amount of the complex II
enzyme SHDA was unchanged (Fig. 5a,b).
Similarly, in a comparison of ICRFa and C57Bl/6 liver
mitochondria, relative amounts of NDUFS3 and NDUFB9 in
the subcomplexes were lower in the long-lived strain (Fig. 5c,d).
Longer exposure of the same blots showed incorporation of
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Figure 3 | Lower abundance of complex I matrix subunits in long-living mice. All data are mean±s.e.m. from four animals per group, *Po0.05,
**Po0.01 (t-test). (a) SDS–PAGE western blots of complex I matrix arm subunits NDUFS3 and NDUFV2, PhB and membrane arm subunits NDUFA9 and
NDUFB9 in liver mitochondria. Each sample is from a different animal. (b) Relative abundance of matrix subunits NDUFS3 and NDUFV2 and PhB to
membrane subunits NDUFA9 and NDUFB9 in liver mitochondria from 7–8-month-old C57Bl/6 mice under AL (open bars) and DR (filled bars). (c) As in b,
comparing long-lived ICRFa mice (filled bars) with control C57Bl/6 (open bars) at 7–8 months of age. (d) As in b, comparing young (filled bars) to old
(open bars) ICRFa liver mitochondria. (e) SDS–PAGE western blots of the indicated proteins in brain mitochondria. (f) Relative abundance of matrix
subunits NDUFS3 and NDUFV2 and PhB to the membrane subunit NDUFA9 in brain mitochondria from 15-month-old C57Bl/6 mice under AL (open bars)
and DR (started at 3 months of age, filled bars). (g) SDS–PAGE western blots of the indicated complex I subunits in skeletal muscle mitochondria.
(h) Relative abundance of matrix subunit NDUFV2 to the membrane subunit NDUFB9 in muscle mitochondria from 15-month-old C57Bl/6 mice under
AL (open bar) and DR (filled bar).
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NDUFS3, NDUFV2 and NDUFB9 into multiple subcomplexes
that overlap with bands of weak complex I activity
(Supplementary Fig. 5A). Even in these low-molecular-weight
subcomplexes, less NDUFS3 and NDUFB9 was incorporated in
the long-lived ICRFa strain (Supplementary Fig. 5B).
To assess the distribution of complex I subunits between the
holoenzyme and subcomplexes more comprehensively, we
performed complexome profiling in mouse liver mitochondria13.
BN gels were cut into 12 slices covering the holocomplex (slice 1)
and subcomplexes of different sizes (slices 2–12; Fig. 5e).
The protein content in each slice was determined by
spectral counting-based label-free semiquantitative proteomics
(Supplementary Tables 4–7). We quantified 36 of the 44 complex
I subunits (plus NDUFA4, which has now been identified as a
complex IV subunit14). We compared C57Bl/6 and ICRFa mice at
8 months of age as well as AL and DR C57Bl/6 mice at 15 months
of age (following 12 months of DR) with three mice analysed
separately per group. Peptide counts of the various proteins
making up the holoenzyme were widely different, even after
normalization for total peptide counts per mouse (Supplementary
Tables 4–7). The detection efficiency in the major (holocomplex)
slice in our proteomic approach is similar to other recent
proteome profiling approaches13,14. Importantly, our counts were
highly reproducible between experiments and mice with an
average standard error below 15% (Supplementary Tables 4–7).
Relative amounts of all complex I proteins that were detected
in subcomplexes are shown in the heatmaps (Fig. 5f–i) assuming
equimolar stoichiometry in the holocomplex. It should be noted
that equimolar stoichiometry in the mammalian complex I
holocomplex has so far been proven for only 7 out of 14 tested
complex I subunits12, therefore, absolute quantification should
not be attempted from these data. Our results indicate that
complex I subunits NDUFA7, 10 and 12 are exclusively found in
smaller (below 200 kDa) subcomplexes (and in the holocomplex),
whereas most other subunits are preferentially located in larger
complexes (4500 kDa). Importantly, comparisons between the
treatments show less matrix subunits in subcomplexes in mice
treated with DR (compare Fig. 5g,f) and in ICRFa (Fig. 5i) versus
C57Bl/6 (Fig. 5h) mice at the same age. In fact, hardly any
complex I subcomplexes could be found in 8-month-old ICRFa
mice (Fig. 5i). Moreover, a comparison between C57Bl/6 mice
under AL feeding shows increased accumulation of subcomplexes
from 8 months (Fig. 5h) to 15 months (Fig. 5f) of age. Taken
together, these experiments suggest that complex I in liver
mitochondria is more efficiently assembled in long-living mice,
and this is counteracted by increasing age.
Less efficient complex I assembly increases ROS and senescence.
The catalytic subunits of complex I are located in the matrix arm,
but proton pumping occurs via the membrane arm; hence the
electron transfer to the Q-pool is only possible with the fully
assembled complex I. ‘Superfluous’ matrix subunits may produce
superoxide on its own15 without involving electron transfer
activity in the ETC. We hypothesized that less complete assembly
of complex I should result in less efficient electron transfer and
oxidative pohsphorylation (OXPHOS)-dependent ATP
production per unit of substrate used, and higher ROS
production. To test this hypothesis, we disrupted the complex I
assembly by small interfering RNA (siRNA)-mediated gene
2,000
6
45
NDUFS3
NDUFV2
PhB
NDUFA9
NDUFB9
UQ
NDUFS3
NDUFV2
PhB
NDUFA9
NDUFB9
UQ
R
el
at
ive
 a
bu
n
da
nc
e
1.2
* ** *
Cont
Rapa
0.8
0.6
0.4
0.2
0.0
1.2
* * ** *
Cont
Rapa
1.0
0.8
0.6
0.4
0.2
0.0
FS
3/
FA
9
FS
3/
FB
9
FV
2/
FA
9
FV
2/
FB
9
Ph
b/
FA
9
Ph
b/
FB
9
FS
3/
FA
9
FS
3/
FB
9
FV
2/
FA
9
FV
2/
FB
9
Ph
b/
FA
9
Ph
b/
FB
9
R
el
at
ive
 
a
bu
n
da
nc
e
1.0
40
35
30
25
**
*
20
15
10
5
0
25
20
15
10
5
0 C
57
BI
/6
 c
on
t
C5
7B
I/6
 ra
pa
C5
7B
I/6
 c
on
t
C5
7B
I/6
 ra
pa
C5
7B
I/6
 c
on
t
C5
7B
I/6
 ra
pa
Na
tive
CI 
ma
x
Cont
Rapa
Cont
Rapa
4
2
0 C5
7B
I/6
 c
on
t
C5
7B
I/6
 ra
pa
C5
7B
I/6
 c
on
t
C5
7B
I/6
 ra
pa
C5
7B
I/6
 c
on
t
C5
7B
I/6
 ra
pa
Cont
Rapa
Cont
Rapa
Cont
Rapa
Cont
Rapa
1,500
1,000
500
0
1,200 10
8
6
4
2
0
R
es
pi
ra
to
ry
 c
on
tro
l r
a
tio
1,000
800
600
400
200
0
PM Succ
PM Succ PM Succ
PM
Na
tive
CI 
ma
xSucc
pm
ol
es
 O
2
 
m
in
–
1  
pe
r 5
 μ
g 
pr
ot
ei
n
pm
ol
es
 O
2
 
m
in
–
1  
pe
r 5
 μ
g 
pr
ot
ei
n
pm
ol
es
 H
2
O
2
 
m
in
–
1  
pe
r m
g 
pr
ot
ei
n
pm
ol
es
 H
2
O
2
 
m
in
–
1  
m
g 
pr
ot
ei
n
R
es
pi
ra
to
ry
 c
on
tro
l r
a
tio
Figure 4 | Rapamycin treatment reduces ROS production and complex I matrix arm components. All data are mean±s.e.m., 4–5 animals per group,
*Po0.05, **Po0.01 (t-test). (a–d) Liver mitochondria from control (Cont) and rapamycin (Rapa)-treated mice. (a) Oxygen consumption rates with
pyruvate/malate (PM) or succinate (Succ) as substrate. Left: state 3 respiration rates; and right: respiratory control ratios. (b) H2O2 release under native
conditions using PM without inhibitors (native) and under PMþ rotenone (CI max). (c) SDS–PAGE western blots of complex I matrix arm subunits
NDUFS3 and NDUFV2, prohibitin (PhB), membrane arm subunits NDUFA9 and NDUFB9 and UQCRC2 (UQ), a complex III subunit as complex
I-independent reference. Please see Supplementary Fig. 4 for uncropped scans of the blots. (d) Relative abundance of matrix subunits NDUFS3 and
NDUFV2 and PhB to membrane subunits NDUFA9 and NDUFB9. (e–h) Same as a–d, but from brain mitochondria.
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silencing of the complex I assembly factor NDUFAF1 in HeLa
cells (Fig. 6a), which increases the relative abundance of partially
assembled complex I16, decreasing protein abundance and
activity in the holocomplex (Fig. 6f). Reduction of NDUFAF1
protein abundance to o50% was not associated with changes in
the amount of the complex II protein SDHA, but with a
potentially compensatory increase of PhB (Fig. 6a). This was
associated with lower oligomycin-sensitive oxygen consumption
and higher basal acidification rates in the medium
(Supplementary Fig. 6), resulting in lower mitochondrial
OXPHOS and higher glycolytic ATP production (Fig. 6b).
Furthermore, despite lower basal oxygen consumption rates
(Supplementary Fig. 6), mitochondrial superoxide production
was increased as measured by fluorescence intensity of MitoSOX,
a dihydroethidine (DHE) derivative directed into mitochondria
(Fig. 6c). Fluorescence of the pan-cellular superoxide-sensitive
dye DHE was slightly but significantly increased, and hydrogen
peroxide release from complex I in isolated HeLa cell
mitochondria under basal conditions was also increased
following NDUFAF1 knockdown, with a tendency to increased
H2O2 release under maximum stimulated respiration as
well (Fig. 6d). However, dihydrorhodamine-123 (DHR-123)
fluorescence indicating cellular peroxide levels was unchanged
(Fig. 6c), which might indicate that under the given experimental
conditions in HeLa cells hydrogen peroxide was still efficiently
detoxified by cytoplasmic antioxidants. Together, these data
indicate that mitochondrial superoxide production increased
despite of lower OXPHOS activity as a result of NDUFAF1
knockdown.
PhBs may act as chaperones for incompletely assembled
complex I subunits. To test this idea, we performed double
knockdowns for NDUFAF1 and PhB in HeLa cells (Fig. 6e; see
Supplementary Fig. 7 for uncropped scans). NDUFAF1 knock-
down alone reduced activity of the fully assembled complex I
(Fig. 6f) as described before16. It also decreased protein
abundance in the holocomplex with a preference for matrix
arm proteins (Fig. 6f). Importantly, both activity and protein
abundance were restored by additional siRNA-mediated
suppression of PhB (Fig. 6f). Moreover, knockdown of PhB
completely rescued the increase in mitochondrial superoxide in
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Figure 5 | Efficient complex I assembly in long-living mice. (a) BN gels/western blots of the indicated subunits of complexes I and II in mice liver
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bands on the complex I activity gel. Arrowheads mark the positions of subcomplexes quantified in b. (b) Normalized ratios of subcomplex/holocomplex
band intensity (complex I subunits) or relative intensity (SDHA) on BN gel western blots. Data are mean±s.e.m. from four animals per group, *Po0.05,
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matrix arm subunits, Membrycomplex I membrane arm subunits.
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NDUFAF1 KD cells (Fig. 6g). It also tended to rescue hydrogen
peroxide release from isolated HeLa mitochondria under
conditions of maximum ROS production (Supplementary Fig. 8).
Finally, we asked the question whether disruption of
complex I assembly would induce somatic cell ageing.
When NDUFAF1 was reduced by siRNA-mediated knockdown
in primary human MRC5 fibroblasts (Fig. 6h; see Supplementary
Fig. 9 for uncropped scans ), cell growth was decelerated and
cells became positive for senescence (Sen)-associated
b-galactosidase (Fig. 6i), an established marker for cell senes-
cence17. The increase in the frequency of Sen-b-Gal-positive cells
was highly significant (Fig. 6j), indicating that disturbance of
complex I assembly induced premature senescence of normal
somatic cells.
Discussion
Few earlier studies examined changes in the liver mitochondrial
proteome between young, old and dietary restricted animals.
These identified a low number of ETC subunits, generally at
lower abundance under DR and increased in old animals18–20,
which is consistent with our data. Similar results were found in
other tissues including skeletal muscle21 and heart22,23, although
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Data are mean±s.e.m., n¼ 6. **Po0.001, Student’s t-test.
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Ghosh et al.24 reported that ageing reduced some ETC subunits
along with decreased ROS production in human skeletal
mitochondria. In-depth interpretation of many of these studies
has been hampered by low coverage and/or sensitivity.
We focused on changes that occur in the mitochondrial
proteome of long-living animals at an early age and thus might be
causally involved in longevity. We chose two models of longevity:
DR, which leads to a robust extension of lifespan in our C57Bl/6
mice25, and comparison between two strains (C57Bl/6 and
ICRFa). We used a gel-free quantitative proteomics approach
enabling detection of a large fraction of the mitochondrial
proteins without recognizable bias against hydrophobic
polypeptides. Use of a novel Bayesian model to evaluate the
significance of differences in protein abundance from the
measured peptide label distributions26 allowed high confidence
even in relatively small fold-changes in protein abundance.
Although we were aware of issues with the accuracy of relative
quantification owing to signal compression effects when using
isobaric approaches such as TMT27, these do not affect our
conclusions as they are based on high-confidence protein
abundance changes, not on their magnitude.
Critically, what was common in long-lived animals was the low
abundance of many of the ETC subunits proteins at a young age,
which was reversed at old age. Downregulation of individual
components of the ETC has been found to extend lifespan in
Podospora anserina28, Caenorhabditis elegans29,30 and Drosophila
melanogaster31, and resulted in lower acceleration of mortality
with age in mice32. In these models, successful lifespan extension
was often ascribed to induction of stress–response pathways,
specifically the mitochondrial unfolded protein response33,34,
although we did not see evidence for it in our long-living mice.
Our data suggest that a coordinated decrease of ETC protein
abundance, as found in the mitochondria from long-living mice,
does not necessarily compromise mitochondrial function,
so far as it supports efficient complex (and, possibly, ETC
supercomplex) formation. In fact, emerging data indicate close
interactions among supercomplex formation, ETC stability and
ETC functionality, showing that supercomplex destabilization
might contribute to increased ROS production during ageing35.
Our study identified low abundance of complex I matrix arm
subunits as the common feature in multiple tissues and multiple
intervention models in long-living mice. Recent metabolic labelling
study in mice5 showed that matrix arm proteins had shorter half-
lives than membrane arm proteins in liver and heart, which is in
agreement with the idea that matrix arm proteins might exist to a
larger extent as free monomers or in less stable, smaller complexes.
Furthermore, Lambert et al.36 identified low complex I content as
the most probable explanation of the low hydrogen peroxide release
in pigeon heart mitochondria as compared with the mouse. Our
data specify this result by correlating the abundance of complex I
matrix subunits with ROS production.
The structure of the mammalian complex I holocomplex is still
far from clear37. So far, stoichiometric relationships have only
been established for 7 out of the 44 subunits in the holoenzyme12.
However, at least in HEK293 cells, the majority of complex I
subunits exists in a steady-state equilibrium between
supercomplexes, the holocomplex and subcomplexes12,13. Our
data confirm this finding for mitochondria in mouse liver.
Importantly, we show that lower amounts of matrix arm subunits
in mitochondria from long-lived mice are associated with a shift
in the equilibrium from subcomplexes towards the holocomplex,
suggesting that the relative abundance of the matrix subunits is a
particularly important factor for functional optimization through
more complete complex I assembly status.
Based on our data, we propose the following model (Fig. 7):
relatively low abundance of matrix arm subunits favours more
complete assembly of complex I. This enables efficient use of
substrate for proton pumping and electron transport, resulting in
high efficacy of ATP generation and only obligatory levels of
superoxide production during normal electron transfer. It might
be an adaptation to DR or other longevity-enabling intervention,
which is independent from proton leak-mediated regulation of
efficacy of ATP synthesis, and is associated with limited ROS
production and long lifespan (Fig. 7, left). There are various
possible mechanisms linking complex I assembly and activity
with ROS production. For instance, an inverse relationship
between complex I activity and ROS production was found in
fibroblasts from patients with inherited complex I disorders38.
This might be because of an impact of complex I activity onto the
local redox balance via oxidation of the NAD/NADH pool.
Alternatively, severely compromised complex I activity with
defective proton pumping might be linked to compensatory ATP
hydrolysis by ATP synthase, resulting in high mitochondrial
membrane potential causing high ROS production through
reverse-electron flow at complex I39. However, such an inverse
correlation between complex I activity and ROS production is far
from universal: In many cross-species comparisons and in
multiple DR experiments, lower mitochondrial superoxide
production in long-living cohorts was associated with a lower
or unchanged complex I activity40–43. Our model (Fig. 7) might
explain this apparent paradox.
In old and/or shorter living mice, the relative amounts of
complex I matrix arm subunits are increased, which might be
caused by excessive production or insufficient degradation of
unassembled matrix arm subunits, or by low efficacy of complex I
assembly, although, complex I assembly factors NDUFAF1 and
Acad9 were of equal abundance in all mice (Supplementary
Data 1). The fact that abundance of the chaperone complex, PhB,
changed in parallel to that of complex I matrix arm subunits
(Supplementary Table 1), makes stabilization of unassembled
subunits as its function an attractive possibility (Fig. 7, right).
This was confirmed by our data showing that PhB knockdown
rescued complex I formation and the enhanced complex
I-dependent ROS production in cells with compromised complex
I assembly. It is interesting in this context that diminished
expression of PhBs is associated with pathological conditions
such as chronic obstructive pulmonary disease44, whereas
increased expression of PhBs was associated with oxidative
stress45. Importantly, PhB depletion increased lifespan in
C. elegans mutants with compromised ETC46, thereby
suggesting possible long-term deleterious effects of chaperone-
mediated stabilization of individual ETC components. Partially
assembled subcomplexes of complex I can produce superoxide on
Long lived, young
NADH NADH
NADH
Phb
NADH+ NAD+
NAD+
e– e–
O2– O2–
O2–
H+ H+
Short lived, old
Figure 7 | Non-assembled catalytic matrix arm subunits cause decreased
electron transport and increased ROS production. If complex I is fully
assembled, ROS production is minimum, substrate is used for efficient
proton pumping and electron transport, and this is associated with
longevity (left). Incompletely assembled matrix arm subunits (which might
be stabilized by PhB) can still use substrate and produce superoxide, but
without proton pumping or electron transport, thus reducing the overall
efficiency of the ETC and increasing superoxide output (right).
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their own15 but cannot contribute to electron transfer and proton
pumping, diminishing the efficiency of substrate utilization (Fig. 7,
right). Such a state might be termed ‘mitochondrial cachexia’.
This model might be applicable to a number of mitochondrial
diseases that are caused by mutations in complex I assembly
factors. Cells from these patients accumulate partially assembled
complex I subcomplexes and show impaired mitochondrial
oxygen consumption47. Moreover, aggressiveness of breast
tumour cells in humans has been associated with a high ratio
of matrix (NDUFS3) to membrane subunits (NDUFB9) of
complex I48. According to our results, high NDUFS3/NDUFB9
ratios are indicative of suboptimal complex I assembly, which is
in turn associated with a shift in ATP production from oxidative
phosphorylation towards glycolysis (Fig. 6). Defective complex I
assembly, or generally an imbalance between different subunits of
the ETC, might thus be a mechanistic cause of shifts in the energy
production that has been linked to fast growth and aggressiveness
of tumour cells49.
Moreover, unbalanced complex I assembly might cause
premature cellular senescence by either increased ROS produc-
tion inducing DNA damage, including premature telomere
shortening50–52, by changed energy metabolism53, or both. Cell
senescence is mechanistically linked to accelerated ageing:
Senescent cells increase with age in multiple tissues of mice54
and primates55 and decrease in frequency under DR56. They
secrete bioactive molecules including cytokines57 and ROS58 that
can damage neighbouring cells59. Targeted ablation of senescent
cells rescued age-related functional deterioration in multiple
tissues in at least one progeroid mouse model60. Together, these
data provide a mechanistic link between mitochondrial complex I
homeostasis, cell senescence and organism ageing.
In conclusion, our data suggest the intriguing possibility that
differences in the ratio of matrix to membrane subunits and the
completeness of the assembly of complex I could contribute to
more efficient regulation of the energy producing machinery that
in turn limits excessive ROS production by complex I and enables
enhanced longevity. This might lead to novel intervention
approaches in areas as different as sarcopenia, oncology or frailty.
Methods
Mice. C57Bl/6 male mice were purchased from Harlan (Blackthorn, UK) or
(for the rapamycin experiment) backcrossed from TERCþ / mice (strain
B6.Cg-Terctm1Rdp/J, Jackson Laboratories). ICRFa are a substrain of C57Bl/6
(ref. 7) kept as a long-established ageing colony at Newcastle. Male mice were
housed25 in cages (56 cm 38 cm 18 cm, North Kent Plastics, Kent, UK) of
groups of 4–6 that did not change from weaning. Mice were provided with saw
dust and paper bedding and had AL access to water. Mice were housed at 20±2 C
under a 12-h light/12-h dark photoperiod with lights on at 7:00 am. Group sizes for
lifespan experiments were (censored events in brackets): C57Bl/6 AL 310 (172),
C57Bl/6 DR 241 (157) and ICRFa 2391 (1,061). DR at 60% of AL intake was
initiated at 3 months of age and lasted for either 5 or 12 months. DR at 60% of AL
intake was initiated at 3 months of age and lasted for either 5 or 12 months. For the
rapamycin experiment, control chow was supplemented with 0.067mg of
rapamycin per day per mouse10,61 (gift from John Strong, TX, USA). All work
complied with the guiding principles for the care and use of laboratory animals
and was licensed by the UK Home Office (PPL60/3864).
Mitochondrial isolation. Mouse liver was chopped and rinsed in ice-cold isolation
medium (250mM sucrose, 5mM Tris Base and 2mM EGTA, pH 7.4, at 4 C), and
was homogenized by a glass homogenizer (Wheaton 15ml Dounce tissue grinder)
using six strokes with a loose-fit pestle and centrifuged at 1,050 g for 3min. The
supernatant was centrifuged at 11,630 g for 10min, and the pellet was washed two
more times in isolation medium. The resultant pellet was resuspended in 0.5ml of
isolation medium (crude mitochondria) followed by purification by Percoll density
centrifugation using a stepwise density gradient of 2ml 80%, 6ml 52% and 6ml
26% Percoll in isolation medium, at 41,100 g for 45min. The mitochondria were
collected from the 26%/52% interface and washed twice with isolation medium at
11,600 g to obtain the purified mitochondria62.
Mouse brain mitochondria were isolated from whole brain. The brain was
removed and put in ice-cold isolation medium (250mM sucrose, 10mM Tris base
and 0.5mM EDTA, pH 7.4, at 4 C ) as quickly as possible after the mouse was
killed, homogenized using a glass homogenizer (Wheaton 15ml Dounce tissue
grinder) with eight strokes with a loose-fitting pestle and centrifuged at 2,000 g for
3min. The supernatant was collected and centrifuged at 12,500 g for 10min to
obtain the pellet. The pellet was resuspended in 3% Ficoll solution (diluted from 6%
Ficoll solution with water) and carefully layered onto the 6% Ficoll solution
(240mM mannitol, 60mM sucrose, 50 mM EDTA and 10mM Tris base, pH 7.4 C,
with 6% (w/w) Ficoll) and centrifuged at 11,500 g for 15min. The supernatant was
sharply decanted and the loose, fluffy top layer of the pellet was removed. The
resultant pellet was resuspended with isolation medium and centrifuged at 11,500 g
for 10min to obtain the mitochondrial pellet4.
Mitochondria from HeLa cells were isolated using a mitochondrial isolation kit
(MACS Miltenyi Biotec) according to the manufacturer’s instructions.
Mitochondrial proteomics by TMT labelling.. Frozen mitochondrial pellets
were disrupted by three cycles of thawing on ice and refreezing in liquid N2.
Subsequently, 150 mg protein per sample were dissolved in 50 ml of 1.5M urea and
90mM triethylammonium bicarbonate, pH 8. Samples were reduced with 5 ml of
200mM Tris(2-carboxyethyl)phosphine in 50mM triethylammonium bicarbonate
at 55 C for 1 h, followed by the addition of 5 ml of 375mM iodoacetamide
(AppliChem) and incubation for 30min at room temperature in the dark. Proteins
were digested with trypsin (1:50 w/w) overnight. Peptides were labelled with 6-plex
Tandem Mass Tags (TMT) (Pierce, Cramlington, UK) according to manufacturer’s
instructions. Samples were analysed in two sets of experiments (Expt1 and Expt2),
each containing one-pooled sample for cross-standardization. In addition to the
pool sample, Expt1 consisted of 3 DR and 2 AL C57/Bl6 and Expt2 included
2 young ICRFa, 2 old ICRFa and 1 AL C57/Bl6. Every experimental sample
was from one separate animal.
Samples were separated into 11 (Expt1) or 10 (Expt2) fractions using a 3100
Offgel fractionator (Agilent) following the manufacturer’s instructions. Peptides
from each fraction were analysed on Dionex Ultimate 3000 nano-HPLC system
with a Dionex PepMap column (75 mm 250mm) coupled to an Orbitrap LTQ XL
mass spectrometer. Peptides were eluted with a gradient from 5% acetonitrile
(MeCN), 0.08% formic acid to 60% MeCN, 0.08% formic acid over 132min. The
capillary voltage was set to 200 C and the spray voltage to 1.6 kV. Survey scans
were acquired in the Orbitrap with a resolution of 30,000 at m/z 400Da. Up to
three sets of data-dependent MSMS scans were acquired for the three most intense
precursor ions, with a collision-induced dissociation (CID) spectrum (in the LTQ)
and an higher energy collision dissociation (HCD) spectrum (in the Orbitrap)
triggered for the same precursor. CID was performed with a target value of 10,000
in the linear ion trap, collision energy of 35%, Q value of 0.25 and an activation
time of 30ms. HCD spectra were acquired with a resolution of 7,500 (at m/z 400)
and a collision energy of 60%.
Raw data were processed using ProteomeDiscoverer v 1.1 (Thermo). HCD
spectra were used for the ‘reporter ions quantizer’ node using an integration
window tolerance of 20 p.p.m. and TMT batch-specific isotope impurity correction
factors and raw quan values as an output variable. Using Proteome Discoverer as
an interface, a concatenated database containing mouse proteins from swissprot
(v 2010_04), trembl (v 2010_04) and cRAP (ftp://ftp.thegpm.org/fasta/cRAP),
containing a total of 55,309 sequences, was searched with the CID and the HCD
spectra using Mascot v. 2.2 (Matrix Science) and the following parameters: 1
missed tryptic cleavage site, 1% FDR (determined using a reversed decoy database),
10 p.p.m. precursor tolerance, 0.8Da fragment ion tolerance, carbamidomethyl (on
Cys) and 6-plex TMT (on N-termini and on Lys) as fixed modifications, oxidation
(Met), deamidation (Gln and Asn), acetylation (Lys) and pyro-Glu as variable
modifications. Quantitation and identification results were exported together as tsv
files. Using an in-house written script, these files were then converted into a format
that was suitable for processing by the purpose-written Bayesian tool dpeaqms
(deposited on R-forge, http://r-forge.r-project.org/projects/dpeaqms/). Dpeaqms26
uses a Bayesian approach and Markov Chain Monte Carlo methods to calculate the
posterior probability b that the conducted experiments indicate a systematic
change in protein concentration between groups. The statistical model takes into
account (i) a sample specific normalization term (to account for loading
differences); (ii) a mean reporter ion intensity (assuming no systematic differences)
for an MSMS spectrum; (iii) the mean difference in log intensity in which a
systematic difference between a sample’s group and the reference group is
observed; and (iv) independent and identically distributed noise terms following
a normal distribution. A bZ0.5 was chosen as threshold for different abundance,
accepting a FDR in the order of 1% (ref. 26).
To perform group comparisons across both experiments, that is, for the DR–AL
and the ICRFa–C57Bl/6 comparisons, pooled samples were used as a standard
(combined analysis). A DR–AL comparison was also performed within Expt1 only,
and the young–old comparison was only made in Expt2. For these comparisons,
the data were analysed within the set and the pooled sample was not used (solo
analyses). In the DR–AL comparison, there were 139 and 141proteins significantly
different in abundance using combined or solo analysis, respectively. Calculated
b values and fold changes were very similar for most of the proteins. Only 10
proteins were found altered in the solo analysis but not in the combined one, and
eight proteins were altered in the combined analysis but not in the solo analysis
(Supplementary Table 1A). This validates our use of pooled samples as a standard and
indicates that the chosen number of animals are sufficient for a robust estimate of
differences. For the final DR–AL comparison, we considered proteins as confidently
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different in abundance only when their b values were Z0.5 in both sets of analysis.
The results for all the comparisons are presented as Supplementary Data 1.
For mitochondria-specific KEGG pathway enrichment analysis, KEGG pathway
finder was used to identify all KEGG pathways that contain at least one mitochondrial
protein that has changed with a probability b40.5. Next, all mitochondrial proteins
belonging to each identified KEGG pathway were identified using MitoMiner v2
(ref. 8). KEGG pathway terms enrichment analysis was performed in R with a
hypergeometric distribution function separately for proteins that were either more or
less abundant under DR. This was compared with enrichment of the same pathways
based on proteins more or less abundant, respectively, in young or old ICRFa.
Heatmaps of the ETC subunits were drawn using Cytoscape.
Mitochondrial complex I profiling. Mitochondria were solubilized in sample
buffer (50mM BisTris, 6N HCl and 50mM NaCl, 10% w/v glycerol, pH 7.2) with
detergent dodecylmaltoside at 3.2 g/g (detergent/protein) ratio. The samples were
separated by BN gel electrophoresis according to manufacturer’s instructions (Life
Technologies), using a 4–16% gel. Gel lanes were cut into 12 slices (Fig. 4e), which
were destained, reduced using 10mM Dithiothreitol (AppliChem) and alkylated in
the dark using 50mM iodoacetamide (AppliChem before digestion with trypsin
(Promega) for 18 h. The digested peptides were extracted from the gel pieces,
desalted using stage tips63, concentrated in a speedvac and acidified using 1%
trifluoroacetic acid.
Peptides were separated using a PepMap column (250mm 75mm, Thermo) and
a water/acetonitrile gradient from 4–40% acetonitrile over 100min. A combination of
data from preliminary experiments and gpmdb64 was used to generate an accurate
mass inclusion list65 in XCalibur. Peptide retention times in the inclusion lists were
either obtained from our own experimental data or estimated using the pyteomics
python framework. Precursor ions were detected in positive mode at 350–1,600m/z
with a resolution of 60,000 (at 400m/z) and a fill target of 500,000 ions and a
lockmass was set to 445.120023m/z. The six most intense ions of the inclusion list
(with a target value of 1,000 ions) followed by the four most intense other ions (also
with a target value of 1,000 ions) in each MS scan were isolated, fragmented using
CID and a normalized collision energy of 35 eV and measured in the linear ion trap.
Peaklists in the Mascot generic format (*.mgf) were generated using msconvert
(proteowizard.sourceforge.net)66 and the mouse proteome (ensembl NCBI 37.64) was
searched using an in-house installation of X!Tandem with the gpm interface67
(version 2013.09.01.1) and carbamidomethylation set as a fixed modification,
methionine oxidation as a variable modification. Two refinement steps were included
in the search to include deamidation and methylation artefacts occurring in the gel.
The protein level false-positive rate (as defined in: http://wiki.thegpm.org/wiki/
False_positive_rate) for all searches was o1%.
BioML files obtained from X!Tandem were parsed and the results were
annotated using in-house written python scripts (available from the authors upon
request). Peptide and protein sequences were extracted, annotated with band
position, repeat number (1–3) and experimental treatment, peptide lists were
filtered to include only complex I peptides, PhB and NDUFA4 and rolled up into
protein lists. The number of peptides found for each protein in each band was
normalized by dividing it by the number of all identified peptides for the
corresponding lane (mitochondrial sample) in the BN gel and then multiplied with
106. Normalized peptide counts were averaged over three mice per group analysed
independently. Averaged counts were used to generate heatmaps following
normalization to counts in slice 1 (the holocomplex).
Functional experiments. Mitochondrial oxygen consumption rates were
measured using Seahorse XF 24 analyzer according to the manufacturer’s
instructions (see also ref. 68 and comments therein). Five micrograms per well
mitochondria were attached to the 24-well plate by centrifugation (2,500g for
10min at 4 C), and oxygen consumption rates were measured in the assay buffer
(115mM KCl, 10mM KH2PO4, 2mM MgCl2, 3mM HEPES, 1mM EGTA and
0.2% fatty acid-free BSA, pH 7.2, at 37 C) with substrate (5mM pyruvate and
5mM malate for complex I-linked substrate or 4mM succinate for complex II-
linked substrate). State 3 oxygen consumption rates were obtained by adding 4mM
ADP. Mitochondrial hydrogen peroxide release was measured fluorometrically in
the presence of exogenous superoxide dismutase (15U ml 1), horseradish
peroxidise (2Uml 1) and Amplex red (50mM) at 37 C, and the fluorescence
signals were calibrated against a hydrogen peroxide standard.
Western blots and BN gel. For SDS–PAGE experiments, 20 mg of mitochondrial
proteins or 15 mg of whole-cell extracts were loaded in 15% SDS gels. Membranes
were probed with the following antibodies: NDUFA9 (1:1,000, Abcam, ab14713),
NDUFAF1 (1:10,000, Abcam, ab79826), NDUFS3 (1:1,000, Abcam, ab110246),
NDUFB9 (1:1,000, Abcam, ab106699), NDUFV2 (1:1,000, Proteintech, 15301-1-
AP), PhB (1:1,000, Abcam, ab28172), SDHA (1:1,000, Abcam, ab14715), UQCRC2
(1:1,000, Abcam, ab14745) and tubulin (1:1,000, Cell Signaling, no. 21485).
Proteins separated by BN PAGE were transferred to Polyvinylidene fluoride
(PVDF) membranes and western blotting was performed as above. Alternatively,
the BN gels were used for in-gel activity assays for complex I by incubating the gel
in the assay buffer consisting of 5mM Tris/HCl with 2.5mgml 1 nitrotetrazolium
blue and 0.1mgml 1 NADH (pH 7.4).
Cell transfection experiments. Subconfluent cultures of HeLa or MRC5 cells
were treated with 10 nM each of anti-NDUFAF1 siRNA (Qiagen, SI04312413,
Hs_NDUFAF1_9), anti-PHB siRNA (Qiagen, SI00301175, Hs_PHB_6) or control
siRNA (Qiagen, cat. no. 1027281) in various combinations. Seventy-two hours after
the transfection, cells were stained using either 10 mM DHE, 10 mM DHR-123 or
1 mMMitoSox, and ROS levels were measured by flow cytometry52. Cellular oxygen
consumption and media acidification rates were measured in a Seahorse XF24
analyzer with sequential injections of oligomycin (0.5 mM), Carbonyl cyanide
4-(trifluoromethoxy)phenylhydrazone (FCCP) (2.5 mM), Rotenone (0.5 mM) and
Antimycin (2.5 mM). ATP production rates were calculated according to ref. 69.
MRC5 human fibroblasts were triple transfected at 4–5 day intervals during which
their growth rate was monitored. Cells were stained for Sen-b-Gal activity at 23
days after the first transfection as described17,58.
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